Status:
UNKNOWN
Romanian Kidney Transplant Cardiovascular Risk Registry
Lead Sponsor:
Grigore T. Popa University of Medicine and Pharmacy
Conditions:
Kidney Transplant; Complications
Cardiovascular Diseases
Eligibility:
All Genders
18-75 years
Brief Summary
Kidney transplantation (KT) represents the best treatment for patients with end-stage kidney disease, being associated with improved outcomes and reduced mortality. Although the survival benefit with ...
Detailed Description
• Patients: The inclusion criteria are: 1. age\>18 years; 2. KT recipient. The exclusion criteria are: 1. metallic joint prostheses, cardiac stent or pacemakers, decompensated cirrhosis, pregnancy...
Eligibility Criteria
Inclusion
- age\>18 years;
- Kidney Transplant Recipient.
Exclusion
- metallic joint prostheses, cardiac stent or pacemakers, decompensated cirrhosis, pregnancy and limb amputations (due to bioimpedance technique limitations);
- no prior diagnosis of pulmonary fibrosis, pneumectomy or massive pleural effusion (due to lung ultrasonography limitations);
- active systemic infections (due to difficulties in the interpretation of nespecific inflammation biomarkers in this type of patients);
- absence of congenital heart disease;
- eGFR below 30 ml/min/1.73m2;
- KT vintage of at least 6 months.
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04451356
Start Date
February 1 2020
End Date
December 1 2022
Last Update
June 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
"Dr. C.I. Parhon" Hospital
Iași, Romania